Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medavail Hldg Inc (NQ: MDVL )

0.2411 +0.0146 (+6.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Medavail Hldg Inc

< Previous 1 2 Next >
MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022
From MedAvail Holdings, Inc.
Via Business Wire
MedAvail Announces Technology Partnership with Progressive Care, Inc
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference
From MedAvail Holdings, Inc.
Via Business Wire
MedAvail to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Reports Second Quarter 2022 Financial Results
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Report 2022 Second Quarter Financial Results on August 11, 2022
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Participate in Upcoming Investor Conferences
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Reports First Quarter 2022 Financial Results
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Announces Closing of Private Placement
From MedAvail Holdings, Inc.
Via Business Wire
MedAvail Announces Pricing of $50 Million Private Placement
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Reports Fourth Quarter and Full Year 2021 Financial Results
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Strengthens Leadership Team
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Announces Changes to Executive Management and Board of Directors; Preliminary Fourth Quarter and FY 2021 Results
From MedAvail Holdings Inc.
Via Business Wire
IMA Medical Group Significantly Expands Partnership With MedAvail, Providing Integrated SpotRx Pharmacy Experience
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Present at the Lytham Partners Winter 2021 Investor Conference
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Signs Four SpotRx Locations With Cano Health in California
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Reports Third Quarter 2021 Financial Results
From MedAvail Holdings Inc.
Via Business Wire
InnovaCare Signs Agreement with MedAvail to Open Three SpotRx Locations in Florida
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference
From MedAvail Holdings, Inc.
Via Business Wire
MedAvail to Report 2021 Third Quarter Financial Results on November 8, 2021
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Appoints Ramona Seabaugh as Chief Financial Officer
From MedAvail Holdings Inc.
Via Business Wire
IMA Medical Group Signs Agreement with MedAvail to Open Four SpotRx Locations in Florida
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Reports Second Quarter 2021 Financial Results
From MedAvail Holdings Inc.
Via Business Wire
SpotRx Joins Zipdrug’s Pharmacy Network
From MedAvail Holdings Inc.
Via Business Wire
MedAvail to Report 2021 Second Quarter Financial Results on August 11, 2021
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Introduces New Compliance Packaging Solutions
From MedAvail Holdings Inc.
Via Business Wire
MedAvail Added to Russell 2000® and 3000® Indexes
From MedAvail Holdings Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.